Medtronic PLC (MDT) - Net Assets
Based on the latest financial reports, Medtronic PLC (MDT) has net assets worth $50.07 Billion USD as of April 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($93.03 Billion) and total liabilities ($42.96 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset allocation strategy of Medtronic PLC to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $50.07 Billion |
| % of Total Assets | 53.82% |
| Annual Growth Rate | 13.22% |
| 5-Year Change | -5.03% |
| 10-Year Change | -0.68% |
| Growth Volatility | 29.37 |
Medtronic PLC - Net Assets Trend (1986–2026)
This chart illustrates how Medtronic PLC's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Medtronic PLC market cap and net worth.
Annual Net Assets for Medtronic PLC (1986–2026)
The table below shows the annual net assets of Medtronic PLC from 1986 to 2026. Also explore Medtronic PLC annual equity growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-04-30 | $50.07 Billion | +3.76% |
| 2025-04-30 | $48.26 Billion | -4.29% |
| 2024-04-30 | $50.42 Billion | -2.41% |
| 2023-04-30 | $51.66 Billion | -2.00% |
| 2022-04-30 | $52.72 Billion | +2.17% |
| 2021-04-30 | $51.60 Billion | +1.43% |
| 2020-04-30 | $50.87 Billion | +1.31% |
| 2019-04-30 | $50.21 Billion | -1.20% |
| 2018-04-30 | $50.82 Billion | +0.81% |
| 2017-04-30 | $50.42 Billion | -2.72% |
| 2016-04-30 | $51.83 Billion | -2.63% |
| 2015-04-30 | $53.23 Billion | +173.77% |
| 2014-04-30 | $19.44 Billion | +4.13% |
| 2013-04-30 | $18.67 Billion | +9.10% |
| 2012-04-30 | $17.11 Billion | +7.17% |
| 2011-04-30 | $15.97 Billion | +9.15% |
| 2010-04-30 | $14.63 Billion | +13.84% |
| 2009-04-30 | $12.85 Billion | +11.40% |
| 2008-04-30 | $11.54 Billion | +5.09% |
| 2007-04-30 | $10.98 Billion | +16.99% |
| 2006-04-30 | $9.38 Billion | -10.21% |
| 2005-04-30 | $10.45 Billion | +15.12% |
| 2004-04-30 | $9.08 Billion | +14.81% |
| 2003-04-30 | $7.91 Billion | +22.94% |
| 2002-04-30 | $6.43 Billion | +16.73% |
| 2001-04-30 | $5.51 Billion | +22.67% |
| 2000-04-30 | $4.49 Billion | +22.90% |
| 1999-04-30 | $3.65 Billion | +78.78% |
| 1998-04-30 | $2.04 Billion | +17.07% |
| 1997-04-30 | $1.75 Billion | -2.41% |
| 1996-04-30 | $1.79 Billion | +34.03% |
| 1995-04-30 | $1.33 Billion | +26.72% |
| 1994-04-30 | $1.05 Billion | +25.19% |
| 1993-04-30 | $841.50 Million | +5.65% |
| 1992-04-30 | $796.50 Million | +16.58% |
| 1991-04-30 | $683.20 Million | +26.28% |
| 1990-04-30 | $541.00 Million | +14.23% |
| 1989-04-30 | $473.60 Million | +19.63% |
| 1988-04-30 | $395.90 Million | +2.30% |
| 1987-04-30 | $387.00 Million | +10.98% |
| 1986-04-30 | $348.70 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Medtronic PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9278.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (April 2026)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $32.64 Billion | 65.98% |
| Other Comprehensive Income | $-4.10 Billion | -8.29% |
| Other Components | $20.93 Billion | 42.31% |
| Total Equity | $49.46 Billion | 100.00% |
Medtronic PLC Competitors by Market Cap
The table below lists competitors of Medtronic PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Equinor ASA
OL:EQNR
|
$109.35 Billion |
|
DBS GROUP ADR/4 SD 1
F:DEV
|
$109.87 Billion |
|
Hon Hai Precision Industry Co Ltd
TW:2317
|
$110.20 Billion |
|
FAST RETAIL. CO. ADR 1/10
F:FR70
|
$110.46 Billion |
|
BP p.l.c
MX:BPN
|
$107.90 Billion |
|
Accenture plc
NYSE:ACN
|
$107.58 Billion |
|
Starbucks Corporation
NASDAQ:SBUX
|
$106.76 Billion |
|
SK Square Co Ltd
KO:402340
|
$106.74 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medtronic PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 48,024,000,000 to 49,463,000,000, a change of 1,439,000,000 (3.0%).
- Net income of 4,800,000,000 contributed positively to equity growth.
- Dividend payments of 3,639,000,000 reduced retained earnings.
- Share repurchases of 1,035,000,000 reduced equity.
- New share issuances of 1,054,000,000 increased equity.
- Other comprehensive income increased equity by 183,000,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $4.80 Billion | +9.7% |
| Dividends Paid | $3.64 Billion | -7.36% |
| Share Repurchases | $1.03 Billion | -2.09% |
| Share Issuances | $1.05 Billion | +2.13% |
| Other Comprehensive Income | $183.00 Million | +0.37% |
| Other Changes | $76.00 Million | +0.15% |
| Total Change | $- | 3.00% |
Book Value vs Market Value Analysis
This analysis compares Medtronic PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.30x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 225.91x to 2.30x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1986-04-30 | $0.39 | $88.51 | x |
| 1987-04-30 | $0.47 | $88.51 | x |
| 1988-04-30 | $0.46 | $88.51 | x |
| 1989-04-30 | $0.53 | $88.51 | x |
| 1990-04-30 | $0.60 | $88.51 | x |
| 1991-04-30 | $0.72 | $88.51 | x |
| 1992-04-30 | $0.84 | $88.51 | x |
| 1993-04-30 | $0.90 | $88.51 | x |
| 1994-04-30 | $1.15 | $88.51 | x |
| 1995-04-30 | $1.45 | $88.51 | x |
| 1996-04-30 | $1.88 | $88.51 | x |
| 1997-04-30 | $1.50 | $88.51 | x |
| 1998-04-30 | $1.74 | $88.51 | x |
| 1999-04-30 | $3.12 | $88.51 | x |
| 2000-04-30 | $3.67 | $88.51 | x |
| 2001-04-30 | $4.49 | $88.51 | x |
| 2002-04-30 | $5.25 | $88.51 | x |
| 2003-04-30 | $6.44 | $88.51 | x |
| 2004-04-30 | $7.41 | $88.51 | x |
| 2005-04-30 | $8.57 | $88.51 | x |
| 2006-04-30 | $7.71 | $88.51 | x |
| 2007-04-30 | $9.45 | $88.51 | x |
| 2008-04-30 | $10.10 | $88.51 | x |
| 2009-04-30 | $11.41 | $88.51 | x |
| 2010-04-30 | $13.19 | $88.51 | x |
| 2011-04-30 | $14.76 | $88.51 | x |
| 2012-04-30 | $16.15 | $88.51 | x |
| 2013-04-30 | $18.17 | $88.51 | x |
| 2014-04-30 | $19.18 | $88.51 | x |
| 2015-04-30 | $48.00 | $88.51 | x |
| 2016-04-30 | $36.35 | $88.51 | x |
| 2017-04-30 | $36.15 | $88.51 | x |
| 2018-04-30 | $37.07 | $88.51 | x |
| 2019-04-30 | $36.90 | $88.51 | x |
| 2020-04-30 | $37.55 | $88.51 | x |
| 2021-04-30 | $37.98 | $88.51 | x |
| 2022-04-30 | $38.89 | $88.51 | x |
| 2023-04-30 | $38.63 | $88.51 | x |
| 2024-04-30 | $37.75 | $88.51 | x |
| 2025-04-30 | $37.23 | $88.51 | x |
| 2026-04-30 | $38.40 | $88.51 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medtronic PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.70%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.20%
- • Asset Turnover: 0.39x
- • Equity Multiplier: 1.88x
- Recent ROE (9.70%) is below the historical average (17.10%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1986 | 15.31% | 13.26% | 0.76x | 1.51x | $18.53 Million |
| 1987 | 19.07% | 14.70% | 0.90x | 1.45x | $35.10 Million |
| 1988 | 21.85% | 13.24% | 1.02x | 1.62x | $46.91 Million |
| 1989 | 20.57% | 13.13% | 0.98x | 1.60x | $50.04 Million |
| 1990 | 20.09% | 12.99% | 0.98x | 1.58x | $54.60 Million |
| 1991 | 19.53% | 13.06% | 1.00x | 1.50x | $65.08 Million |
| 1992 | 20.28% | 13.72% | 1.01x | 1.46x | $81.85 Million |
| 1993 | 23.43% | 14.85% | 1.03x | 1.53x | $113.05 Million |
| 1994 | 22.06% | 16.71% | 0.86x | 1.54x | $127.05 Million |
| 1995 | 22.02% | 16.87% | 0.90x | 1.46x | $160.50 Million |
| 1996 | 23.94% | 19.75% | 0.87x | 1.40x | $249.37 Million |
| 1997 | 33.40% | 23.92% | 1.01x | 1.38x | $408.58 Million |
| 1998 | 29.09% | 22.83% | 0.94x | 1.36x | $390.18 Million |
| 1999 | 12.42% | 11.33% | 0.85x | 1.29x | $91.32 Million |
| 2000 | 24.46% | 21.91% | 0.88x | 1.26x | $649.35 Million |
| 2001 | 18.99% | 18.84% | 0.79x | 1.28x | $495.05 Million |
| 2002 | 15.30% | 15.35% | 0.59x | 1.70x | $340.89 Million |
| 2003 | 20.23% | 20.87% | 0.62x | 1.56x | $809.16 Million |
| 2004 | 21.59% | 21.56% | 0.64x | 1.55x | $1.05 Billion |
| 2005 | 17.26% | 17.94% | 0.61x | 1.59x | $758.95 Million |
| 2006 | 27.14% | 22.55% | 0.57x | 2.10x | $1.61 Billion |
| 2007 | 25.53% | 22.78% | 0.63x | 1.78x | $1.70 Billion |
| 2008 | 19.34% | 16.51% | 0.61x | 1.92x | $1.08 Billion |
| 2009 | 16.88% | 14.86% | 0.62x | 1.84x | $883.90 Million |
| 2010 | 21.18% | 19.59% | 0.56x | 1.92x | $1.64 Billion |
| 2011 | 19.39% | 19.43% | 0.52x | 1.91x | $1.50 Billion |
| 2012 | 21.14% | 22.35% | 0.49x | 1.93x | $1.91 Billion |
| 2013 | 18.57% | 20.90% | 0.48x | 1.86x | $1.60 Billion |
| 2014 | 15.76% | 18.02% | 0.45x | 1.95x | $1.12 Billion |
| 2015 | 5.03% | 13.20% | 0.19x | 2.00x | $-2.65 Billion |
| 2016 | 6.83% | 12.27% | 0.29x | 1.92x | $-1.64 Billion |
| 2017 | 8.01% | 13.56% | 0.30x | 1.98x | $-1.00 Billion |
| 2018 | 6.12% | 10.36% | 0.33x | 1.80x | $-1.97 Billion |
| 2019 | 9.25% | 15.16% | 0.34x | 1.79x | $-378.10 Million |
| 2020 | 9.44% | 16.56% | 0.32x | 1.79x | $-284.70 Million |
| 2021 | 7.01% | 11.97% | 0.32x | 1.81x | $-1.54 Billion |
| 2022 | 9.59% | 15.90% | 0.35x | 1.73x | $-216.10 Million |
| 2023 | 7.30% | 12.03% | 0.34x | 1.77x | $-1.39 Billion |
| 2024 | 7.32% | 11.36% | 0.36x | 1.79x | $-1.35 Billion |
| 2025 | 9.71% | 13.90% | 0.37x | 1.91x | $-140.40 Million |
| 2026 | 9.70% | 13.20% | 0.39x | 1.88x | $-146.30 Million |
Industry Comparison
This section compares Medtronic PLC's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,629,180,350
- Average return on equity (ROE) among peers: -96.40%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medtronic PLC (MDT) | $50.07 Billion | 15.31% | 0.86x | $109.30 Billion |
| Abbott Laboratories (ABT) | $14.33 Billion | 22.59% | 1.01x | $175.75 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $4.66 Million |
| Aethlon Medical Inc (AEMD) | $2.30 Million | -269.46% | 0.79x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-879.00K | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $754.31 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $4.38 Million |
| Allurion Technologies, Inc. (ALUR) | $-34.28 Million | 0.00% | 0.00x | $1.11 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $1.96 Million | -680.21% | 0.05x | $3.95 Million |
| Artivion Inc (AORT) | $20.50 Million | 10.73% | 0.15x | $1.12 Billion |
| Apyx Medical Inc (APYX) | $2.22 Million | 4.46% | 0.72x | $119.21 Million |
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardiovert… Read more